AI in Healthcare

What does it mean when a breakthrough takes 17 years to be recognized? Mary-Claire King’s journey from genetic hypothesis to Nobel Prize shortlist reveals a deeper truth about innovation in medicine. Her work, which changed cancer prevention, was validated only after 17 years of skepticism and proof. This delay isn’t just academic — it’s a warning for AI in healthcare: real-world impact often outpaces institutional validation. When AI models predict disease risk or guide prevention, should we wait for consensus — or act on early, life-saving evidence? The answer may lie in how we define 'proof' in a fast-moving field. This insight comes directly from STAT News’ coverage of King’s Nobel Prize consideration: https://www.statnews.com/2026/10/02/nobel-prize-2026-geneticist-mary-claire-king-long-waiting-not-getting-winner-call/?utm_campaign=rss Source: https://www.statnews.com/2026/10/02/nobel-prize-2026-geneticist-mary-claire-king-long-waiting-not-getting-winner-call/?utm_campaign=rss View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/reports/linkedin-groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request. MIT, Nvidia, Google & IBM-Trained. Cross Domain-Expert: Quantum, AI, Ethics, Sovereignty, Intelligence, Philanthropy. Solepoint Planning. VUI AI Cloud Architect. AI Certifications Development. Quant/AI Instructor. Castor Venture Club Member. Associate Broker. George Arnold Alexander III, MPA Director, ALEX Companies Associate Broker, Alexander Tiffany Southwest, LLC dba ALEX.realestate, et.al. Texas License #574878-B · Broker License #565194-BB Broker, ALEX Real Estate · North Carolina License #367733 Independent Broker, ALEX Real Estate · Colorado License #II.100112456 [email protected] · +1 713.918.9951